Stephen W Morton

Title: Innovations in Cancer Treatment by Stephen W. Morton

Introduction

Stephen W. Morton is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of cancer treatment, particularly in addressing drug-resistant cancers. His innovative approaches have the potential to change the landscape of cancer therapies.

Latest Patents

Stephen W. Morton holds a patent for "Compositions and methods of treatment of drug resistant cancers." This patent focuses on the time-staggered inhibition of EGFR, in combination with DNA damaging agents. This therapeutic strategy is particularly useful for treating drug-resistant cancers, such as a subset of triple-negative tumors that exhibit high basal levels of phosphorylated EGFR. The staggered therapy has also shown applicability to other tumor types, especially lung cancers. The method involves administering the first drug in a dosage and duration sufficient to activate an apoptotic process, which is crucial for sensitizing cancer cells to DNA damage.

Career Highlights

Stephen W. Morton is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research in cancer therapies. His work has garnered attention for its innovative approach to overcoming challenges in treating resistant cancer types.

Collaborations

Stephen has collaborated with notable colleagues, including Michael B. Yaffe and Michael Jungho Lee. Their combined expertise contributes to the ongoing research and development of effective cancer treatments.

Conclusion

Stephen W. Morton is a pioneering inventor whose work in cancer treatment exemplifies the potential of innovative therapies to address complex medical challenges. His contributions are vital in the fight against drug-resistant cancers, paving the way for future advancements in oncology.